Two letters published in the April 9 issue of the New England Journal of Medicine (JAMA) are blaming the deaths of two patients on an active ingredient in a new drug used to treat multiple sclerosis (MS) and psoriasis. The ingredient, dimethyl fumarate, is thought to work by decreasing inflammation and preventing nerve damage that may cause symptoms of MS and rashes from psoriasis. Dimethyl fumarate is an ingredient in the drugs Tecfidera and Psorinovo. The JAMA letters have linked the ingredients to the deaths of two European women who developed progressive multifocal leukoencephalopathy, or PML, a type of brain ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.